Similarly, multivariate analysis of immune responses in a Phase I/IIa trial with blood-stage P. falciparum vaccine PfRH5 revealed that IgA responses were the variables with the greatest importance that contribute to PMR reduction in malaria-naïve individuals25. Here, CD79A is linked to malaria.